caffeine has been researched along with Myasthenia Gravis in 5 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to evaluate the mechanisms of weakness in muscles of patients with myasthenia gravis (MG), intercostal muscle biopsies were obtained from 9 normal subjects and 6 MG patients, and the compound muscle action potential (AP) and tension responses to nerve and muscle stimulation, and contracture responses on exposure to caffeine, were monitored in vitro." | 3.68 | Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis. ( Grob, D; Namba, T; Nandakumar, NV; Pagala, MK; Ravindran, K; Venkatachari, SA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cafiero, C | 1 |
| Micera, A | 1 |
| Re, A | 1 |
| Schiavone, B | 1 |
| Benincasa, G | 1 |
| Palmirotta, R | 1 |
| Pagala, MK | 1 |
| Nandakumar, NV | 1 |
| Venkatachari, SA | 1 |
| Ravindran, K | 1 |
| Namba, T | 1 |
| Grob, D | 1 |
| Takamori, M | 3 |
| Ishii, N | 1 |
| Mori, M | 1 |
5 other studies available for caffeine and Myasthenia Gravis
| Article | Year |
|---|---|
Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Topics: Acetylcholine; Acetylcholinesterase; Antiviral Agents; Caffeine; COVID-19; Cytokine Release Syndrome | 2022 |
Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis.
Topics: Action Potentials; Adenosine Triphosphatases; Adult; Aged; Biopsy; Caffeine; Electric Stimulation; E | 1990 |
The role of cyclic 3',5'-adenosine monophosphate in neuromuscular transmission.
Topics: Acetylcholine; Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminophylline | 1973 |
Caffeine, calcium, and Eaton-Lambert syndrome.
Topics: Acetylcholine; Action Potentials; Adolescent; Adult; Aged; Anticholesteremic Agents; Bronchial Neopl | 1972 |
[Role of cyclic AMP in neuromuscular transmission--with special reference to the effect of catecholamines, xanthines and calcium on myasthenic syndrome].
Topics: Caffeine; Calcium; Catecholamines; Cyclic AMP; Depression, Chemical; Epinephrine; Evoked Potentials; | 1972 |